Nano vaccine for hepatitis B can be boon for Third WorldAugust 13th, 2008 - 3:19 pm ICT by IANS
Washington, Aug 13 (IANS) A modern day scourge like chronic hepatitis-B infects 400 million people worldwide and claims a million lives every year, even with the availability of three effective vaccines. In many poor countries, refrigerated conditions required for storing vaccines are costly and scarce, not to speak of keeping needles and syringes sterile. The need to have people return for the three shots currently required also limits success.
Now, a new vaccine that avoids these drawbacks has moved a step closer to human trials. Researchers hoped it will help immunise large numbers of children and adults in Africa, Asia and South America, efficiently and safely.
The study suggested that the new type of vaccine would not require cold storage and require fewer shots than current vaccines. For instance, protective immunity with the new vaccine required only two immunisations in animals.
Scientists at the Michigan University Nanotechnology Institute for Medicine and Biological Sciences reported that a novel, needle-less method for getting an immunity-stimulating agent into the body has proved non-toxic and able to produce strong, sustained immune responses in animal studies.
The vaccine is based on a super-fine emulsion of oil, water and surfactants placed in the nose. The nanoemulsion represents a new delivery method for an antigen already used in existing hepatitis B vaccines to activate the body’s immune defences.
“Our results indicate that needle-free nasal immunization, using a combination of nanoemulsion and hepatitis B antigen, could be a safe and effective hepatitis B vaccine, and also provide an alternative booster method for existing vaccines,” said James R. Baker, Jr., the study’s co-author and director of the institute.
The nanoemulsion is made up of soybean oil, alcohol, water and detergents emulsified into droplets less than 400 nanometres. It also avoids temporary pain and redness that results from a shot of current vaccines.
Baker’s team has published earlier studies affirming the promise of nasal nanoemulsions for smallpox, influenza, anthrax and HIV vaccines.
The findings appear online in tPLoS ONE.
- Needle-less hepatitis B nano vaccine shows promise for third world - Aug 13, 2008
- Ensure Hepatitis-B vaccine in hospitals, Uttar Pradesh told (Lead) - Apr 16, 2011
- Hepatitis awareness programme launched for Mumbai slums - Jul 28, 2012
- Five-in-one vaccine led to child deaths: experts - Jul 29, 2010
- Judge's complaint on Hepatitis-B to be heard as PIL - Apr 15, 2011
- Agartala kicks off mission to become Hepatitis free - Apr 15, 2012
- Kerala kids to get new pentavalent vaccine shots - Dec 06, 2011
- Anthrax shot protects simians from lethal infection - Jan 13, 2012
- Needle-free jab developed to beat injection phobia - Jul 19, 2010
- Move Over Flu Shots, Microneedles Are Here To Stay - Jul 20, 2010
- Nasal spray flu vaccine one step closer - Feb 18, 2011
- Beware! You may be more vulnerable to hepatitis than you think (July 28 is World Hepatitis Day) - Jul 27, 2012
- Intensify immunisation efforts: WHO - Apr 21, 2012
- Salmonella-based shots hold promise against fatal diseases - Jun 30, 2011
- Universal flu vaccine shows promise - Jun 08, 2011
Tags: africa asia, chronic hepatitis, cold storage, delivery method, detergents, hepatitis b, hepatitis b antigen, hepatitis b vaccine, immune responses, immunisations, nanoemulsion, oil water, poor countries, protective immunity, r baker, soybean oil, surfactants, temporary pain, three shots, vaccines